Metraipolis › archive › dc_e2fbb27ac818

Predictive biomarkers and preventive strategies for PTLD: a turning point in viro-immunologic precision medicine? — Europe PMC PMID:42158727

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42158727
DOI
10.3389/ti.2026.16305
License (as archived)
solo-consultazione
Archived
2026-11-02T19:01:22.896Z
SHA-256 of the archived text
130e316d6c93718837e8d1fc4ae47b7e1b634ea1523b984e2ea3273f39c394a1
Stable URL of this page
https://metraipolis.com/documento/dc_e2fbb27ac818

How to cite

Predictive biomarkers and preventive strategies for PTLD: a turning point in viro-immunologic precision medicine? — Europe PMC PMID:42158727 — Europe PMC (en), https://europepmc.org/article/MED/42158727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2fbb27ac818 (Metraipolis archive dc_e2fbb27ac818, sha256 130e316d6c93718837e8d1fc4ae47b7e1b634ea1523b984e2ea3273f39c394a1)
BibTeX
@misc{dce2fbb27ac818,
  title = {Predictive biomarkers and preventive strategies for PTLD: a turning point in viro-immunologic precision medicine? — Europe PMC PMID:42158727},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42158727},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2fbb27ac818; sha256 130e316d6c93718837e8d1fc4ae47b7e1b634ea1523b984e2ea3273f39c394a1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42158727. Agents can read the archived copy with the MCP tool read_document.